Physician profile
Nicholas Early
NPI 1679863526
$3,076.25
in general payments reported to CMS, 2019-2025
9 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,677 · 2020: $275 · 2021: $413 · 2022: $55.30 · 2023: $290 · 2024: $199 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,322.27 | 2019-2025 | Evos, Healicoil, Bone Anchors With Arthroscopic Delivery System |
| Cdc Medical LLC | $1,140.00 | 2019 | |
| Ferring Pharmaceuticals INC. | $210.26 | 2019-2023 | Euflexxa |
| Stryker Corporation | $175.37 | 2021-2023 | Mako |
| Depuy Synthes Sales INC. | $129.90 | 2023 | Rigidloop, Fms, Versalok Orthocord |
| Sanofi-Aventis U.S. LLC | $42.85 | 2019-2020 | |
| Medtronic, INC. | $24.34 | 2024 | Intellis Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $17.76 | 2025 | |
| Heraeus Medical, LLC. | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Early listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.